Bio-Thera Kicks Off Phase III Trial For Stelara Rival

Chinese Biosimilars Developer Begins Study For BAT2206 Ustekinumab Candidate

 
• By David Wallace
  
Clinical Trial
Bio-Thera has begun Phase III trials for ustekinumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products